Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care
Public ClinicalTrials.gov record NCT06422689. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
ANCHOR - Assessment of Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
ANCHOR is a prospective, phase IV, interventional, single-arm, open-label study of 1,500 adult participants with symptomatic asthma requiring the use of rescue therapy aimed to compare the asthma exacerbation rates before and after switching from albuterol or levalbuterol to albuterol plus budesonide inhalation aerosol as rescue therapy.
Study identification
- NCT ID
- NCT06422689
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 1,511 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 10, 2024 (Actual)
- Primary completion
- Feb 3, 2027 (Estimated)
- Completion
- Feb 3, 2027 (Estimated)
- Last update posted
- Jul 16, 2026
2024 – 2027
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | North Hollywood | California | 91602 | — |
| Research Site | Walnut Creek | California | 94598 | — |
| Research Site | Louisville | Kentucky | 40217 | — |
| Research Site | Boston | Massachusetts | 02111 | — |
| Research Site | Ann Arbor | Michigan | 48109 | — |
| Research Site | Flint | Michigan | 48532 | — |
| Research Site | Minneapolis | Minnesota | 55425 | — |
| Research Site | Asheville | North Carolina | 28803 | — |
| Research Site | Greenville | North Carolina | 27834 | — |
| Research Site | DuBois | Pennsylvania | 15801 | — |
| Research Site | Austin | Texas | 78738 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06422689, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 16, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06422689 live on ClinicalTrials.gov.